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RESEARCH ARTICLE Open Access
Measuring the impact of oesophagectomy
on physical functioning and physical
activity participation: a prospective study
E. M. Guinan1* , A. E. Bennett2, S. L. Doyle3, L. O’Neill4, J. Gannon4, G. Foley4, J. A. Elliott5, J. O’Sullivan6,
J. V. Reynolds5,6 and J. Hussey4
Abstract
Background: Oesophagectomy remains the only curative intervention for oesophageal cancer, with defined
nutritional and health-related quality of life (HR-QOL) consequences. It follows therefore that there is a significant
risk of decline in physical wellbeing with oesophagectomy however this has been inadequately quantified. This
study prospectively examines change in physical functioning and habitual physical activity participation, from pre-
surgery through 6-months post-oesophagectomy.
Methods: Patients scheduled for oesophagectomy with curative intent were recruited. Key domains of physical
functioning including exercise tolerance (six-minute walk test (6MWT)) and muscle strength (hand-grip strength),
and habitual physical activity participation, including sedentary behaviour (accelerometry) were measured pre-
surgery (T0) and repeated at 1-month (T1) and 6-months (T2) post-surgery. HR-QOL was measured using the
EORTC-QOL C30.
Results: Thirty-six participants were studied (mean age 62.4 (8.8) years, n = 26 male, n = 26 transthoracic
oesophagectomy). Mean 6MWT distance decreased significantly from T0 to T1 (p = 0.006) and returned to T0 levels
between T1 and T2 (p < 0.001). Percentage time spent sedentary increased throughout recovery (p < 0.001) and
remained significantly higher at T2 in comparison to T0 (p = 0.003). In contrast, percentage time spent engaged in
either light or moderate-to-vigorous intensity activity, all reduced significantly (p < 0.001 for both) and remained
significantly lower at T2 in comparison to T0 (p = 0.009 and p = 0.01 respectively). Patients reported deficits in
multiple domains of HR-QOL during recovery including global health status (p = 0.04), physical functioning (p <
0.001) and role functioning (p < 0.001). Role functioning remained a clinically important 33-points lower than pre-
operative values at T2.
Conclusion: Habitual physical activity participation remains significantly impaired at 6-months post-
oesophagectomy. Physical activity is a measurable and modifiable target for physical rehabilitation, which is closely
aligned with patient-reported deficits in role functioning. Rehabilitation aimed at optimising physical health in
oesophageal cancer survivorship is warranted.
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Background
Oesophagectomy is an exemplar model of a complex oper-
ation, with a relatively high postoperative risk of major
morbidity [1], and defined nutritional and health-related
quality of life (HR-QOL) implications [2, 3]. Oesophageal
cancer is the eighth most common cancer globally, with an
estimated 456,000 new cases in 2012 (3.2% of all cancers)
and the sixth most common cause of cancer mortality
(4.9% of all cancer deaths) [4]. Approximately 20% of pa-
tients diagnosed with oesophageal cancer undergo oesopha-
gectomy with curative intent [5]. This complex procedure
involving upper laparotomy usually in combination with
thoracotomy and one lung anaesthesia, and is associated
with significant postoperative morbidity. Postoperative pul-
monary complications (PPCs), which are among the most
serious postoperative morbidity, occur in 15–30% of pa-
tients post-oesophagectomy and are the primary cause of
postoperative mortality, contributing to 45.5–55% of post-
oesophagectomy deaths [6]. In the modern era, surgery is
preceded by chemotherapy or combination chemoradio-
therapy for the majority of patients who present with locally
advanced disease [2]; an approach which has contributed to
5-year survival rates of up to 47% [7]. Accordingly, at a time
when overall survival is improving, there is a growing em-
phasis on the nutritional, physical and emotional wellbeing
of patients undergoing curative treatment for locally ad-
vanced disease [8].
Oesophageal cancer and its treatment, particularly
oesophagectomy, leads to significant anatomic and
physiologic alterations of the gastrointestinal tract and
thus the long-term nutritional implications of curative
treatment for oesophageal cancer are well documented
[9]. Up to 80% of patients are cachexic at presentation
[10], with recent data demonstrating that weight loss,
sarcopenia, malabsorption and altered gut hormone
function persist into survivorship [11–13]. Notwith-
standing the considerable survival advantages of modern
multimodal treatment regimens when compared with
surgery alone [2, 7], chemotherapy and chemoradiother-
apy can adversely impact body composition and muscle
strength [14], with emerging evidence linking loss of
skeletal muscle mass during neoadjuvant therapy with
chemotherapy toxicity and major postoperative compli-
cations [15].
It follows therefore that there is a significant risk of
decline in physical functioning resulting from both cura-
tive treatment for oesophageal cancer and poor nutri-
tional status. Declines in cardiopulmonary fitness, a key
determinant of physical functioning [16], ability to en-
gage in activities of daily living [17], and increased risk
of postoperative complications [18] are reported with
neoadjuvant chemo(radio)therapy [19–21], and associ-
ated with higher mortality risk at 1-year post oesopha-
gectomy [21]. Physical inactivity is associated with
increased postoperative risk following oesophagectomy
[22] and is a defined problem among cancer survivors
[23, 24], associated with HR-QOL [25] and, increasingly,
survival outcomes [26]. While an acute decline in phys-
ical fitness, muscle strength and HR-QOL is described
from pre-oesophagectomy to post-operative discharge
[17], prospective evaluations characterising the impact of
oesophagectomy on physical outcomes, particularly
long-term evaluations of physical functioning, are lack-
ing [27]. Subjectively, patients report perceived deficits
in physical functioning domains of HR-QOL which per-
sist into survivorship [28, 29]; however, the measured
impact of oesophagectomy on physical functioning is in-
adequately quantified. We have previously described def-
icits in cardiorespiratory fitness and moderate-to-
vigorous intensity physical activity participation in
oesophageal cancer survivors at up to two years post-
operatively, in comparison to age- and gender-matched
controls [30], suggesting that curative treatment exerts a
profound and lasting impact on physical status.
With increasing emphasis on survivorship care in
oesophageal cancer, there is a recognised need to better
understand the physical consequences of oesophageal
cancer and its treatment in order to develop tailored re-
habilitation programmes involving exercise and diet pre-
scription to attenuate the impact of treatment on
physical functioning and optimise HR-QOL in recovery
[31]. Cancer survivorship models emphasise that exer-
cise rehabilitation implemented early in the cancer con-
tinuum, particularly within the first 6-months
postoperatively, is likely to have the greatest impact on
HR-QOL [32]. This study therefore seeks to characterise
the impact of oesophagectomy on physical functioning
and habitual physical activity participation in early post-
operative recovery and up to 6-months post-
oesophagectomy to inform targets and priorities for ex-
ercise rehabilitation during this period.
Methods
Study design
Patients with a diagnosis of oesophageal cancer and
scheduled for oesophagectomy were identified from the
upper gastrointestinal clinic at the Oesophageal and
Gastric Centre at St James’s Hospital (SJH), Dublin,
Ireland, a high-volume national centre. Ethical approval
was obtained from the SJH–Tallaght Hospital Joint Re-
search Ethics Committee. Informed written consent was
obtained prior to study commencement. Using a pro-
spective observational design, participants were recruited
pre-operatively and measurements were collected pre-
surgery (T0), at 1-month post-surgery (T1) and at 6-
months post-surgery (T2). Visits were conducted in the
Wellcome Trust-HRB Clinical Research Facility at SJH.
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Clinical treatment
All participants were treated according to standardised
care pathways involving either multimodal therapy or
surgery only. Patients with locally advanced disease re-
ceived either pre- and postoperative chemotherapy as
per the MAGIC regimen [33] or neoadjuvant chemora-
diation as per the CROSS protocol [34]. Surgical resec-
tion was performed at least 6-weeks post neoadjuvant
therapy. The surgical approach involved either transtho-
racic en-bloc oesophagectomy (2-stage or 3-stage) or
transhiatial oesophagectomy following evaluation of pa-
tient demographics and comorbidities as previously de-
scribed [35]. Postoperatively, patients were immediately
extubated and admitted to a monitored bed, normally
the high dependency unit (HDU). Patients were trans-
ferred to the ward on postoperative day (POD)3 or when
medically suitable. The institutional enhanced recovery
after surgery protocol included the following elements;
early enteral feeding via jejunostomy, early mobilisation
and airway clearance techniques from POD1, removal of
chest drains on POD2 and contrast study for anasto-
motic integrity on POD4. Postoperative analgesia was
managed using thoracic epidural analgesia. The jejunost-
omy remained in-situ for 4–6 weeks postoperatively and
supplemental overnight enteral nutrition was continued
on discharge for a planned duration of 4 weeks in all
participants [36]. Patients were reviewed at regular inter-
vals postoperatively by the specialist dietetic service.
Clinical data
Demographic and clinicopathologic data was gathered
from medical charts and from the institutional upper
gastrointestinal cancer database. Postoperative data in-
cluded in-hospital mortality, hospital and critical care
length of stay (LOS) and postoperative complications.
Measures of anthropometry
Weight (kg) was recorded using a calibrated Seca scale.
Height (cm) was measured barefoot using a Seca stadi-
ometer. Body mass index (BMI) was calculated as weight
(kg)/height (m2). Mid-arm circumference (MAC) was
measured in cm at the halfway point between the olecra-
non process of the ulna and the acromion process of the
scapula. Waist circumference (cm) was measured at the
mid-point between the iliac crest and the 12th rib fol-
lowing gentle expiration. MAC and waist circumference
were taken in duplicate and averaged for data entry.
Bioimpedance analysis was used to determine body com-
position and was performed using the Seca mBCA 515
(Seca, Hamburg, Germany).
Measures of physical functioning
Functional exercise performance was measured using
the 6-min walk test (6MWT). Participants walked at
their fastest pace for 6 min along a 30m walkway with
the aim of achieving the furthest distance possible with
standardised verbal encouragement [37]. Isometric hand
grip strength (HGS) (kg) was measured using a handheld
digital dynamometer (Jamar). Measures were taken in
triplicate, bilaterally and the highest measure recorded.
Physical activity was measured using the ActiGraph
GT3X+ triaxial accelerometer (Actigraph Pensacola, FL).
The accelerometer was worn on the hip, secured with an
elastic belt, during waking hours for 7 days following all
study visits. Data were analysed using the Actilife soft-
ware using standardised algorithms to analyse time in
physical activity domains and adherence to physical ac-
tivity guidelines (150 min moderate-to-vigorous intensity
physical activity (MVPA)/week, accumulated in bouts
≥10min [38]). The following cut-points were used to de-
fine activity domains: sedentary 0–99 counts per minute
(CPM), light 100–2019 CPM, moderate 2020–5998 and
vigorous ≥5999 [39]. A valid data was defined as one
with 10 h of data and at least four consecutive days were
required for analysis.
Measures of health-related quality of life
QOL was assessed using the European Organisation for
Research and Treatment of Cancer (EORTC) Core QOL
Questionnaire, the QLQ-C30 (version 3.0). This vali-
dated instrument assessed QOL in functional, symptom
and global domains. Scores for each question were cal-
culated according to the EORTC QLQ-C30 manual and
linearly transformed into a 0–100 scale [40].
Sample-size considerations
This is an exploratory descriptive study, which considers
the impact of oesophagectomy on clinically important
outcomes using a patient-centred, multifaceted ap-
proach. Using previous literature to estimate an effect
size of 0.5 for the effect of treatment for oesophageal
cancer on physical status [14] a significance level of 0.05
and a power of 0.8, a sample size of 33 was calculated
for repeated measures. This sample estimate is consist-
ent with other publications in this field [17].
Statistical analyses
SPSS version 22.0 was used for analyses. Variables were
tested for normality using the Shapiro-Wilks test. Nor-
mally distributed variables were summarised as mean
and standard deviation (SD). Non-normally distributed
data were summarised as median and interquartile range
(IQR). Categorical variables are presented as frequency
(percentage).
A mixed between-within subjects analysis of variance
(ANOVA) was conducted to assess the change in out-
comes across three timepoints in consideration of the
impact of treatment regimen (CROSS, MAGIC or
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surgery only). Data was tested to ensure that the as-
sumptions of homogeneity of variance (Levene’s test for
equal variances) and homogeneity of intercorrelations
(Box’s M statistic) were not violated. Multivariate statis-
tics were interpreted. Interaction effects were examined
and reported where significant. Differences between the
groups were presented as partial eta squared (η2) effect
sizes. The strength of the differences was interpreted as
small (η2 < 0.01), medium (η2 = 0.01–0.06) or large (η2 =
0.06–0.138). Post-hoc pairwise comparison for compari-
son of main effects were examined using Bonferroni
analysis. A Friedman test was used to examine changes
in non-parametric outcomes over the three timepoints.
Associations between measures of anthropometry and
measures of functional performance were assessed using
Pearson Product Moment Correlation Coefficients. Stat-
istical significance was taken at p < 0.05.
Results
Between January 2014 and October 2016, 52 patients were
recruited and tested pre-surgery, of whom 43 returned for
repeat measures 1-month post-surgery and 36 returned at
6-months post-surgery. The mean time between a pre-
surgery assessment and a 1-month post-surgery assess-
ment was 66 (21) days. The mean time between 1-month
and 6-months post-surgery assessments was 157 (42) days.
Reasons for not completing follow-up measurements
were: disease progression (n = 6); prolonged postoperative
morbidity (n = 3); participant death (n = 2) and participant
drop-out (n = 5) (Fig. 1). Demographic characteristics are
presented in Table 1. Demographic characteristics of the
final sample were comparable to those lost to follow-up.
Anthropometry
Body weight, BMI, fat mass, body fat percentage, fat free
mass (FFM), skeletal muscle mass, waist circumference
and MAC all reduced significantly over the study period
(Table 2). Pre-operatively, participants had a mean body
weight of 81.9 (16.4) kg and a mean BMI of 27.8 (4.3 kg/
m2. Male participants had a pre-operative waist circum-
ference of 98.6 (12.3) cm and female participants had a
mean waist circumference of 91.38 (9.8) cm. Percentage
weight loss from pre-surgery to 1-month (− 6.2 (4.3) %)
and to 6-months (− 8.9 (7.4) %) post-surgery was clinic-
ally significant. There was no impact of treatment ap-
proach on weight (p = 0.356, η2 = 0.069), BMI (p = 0.963,
η2 = 0.003), fat mass (p = 0.0.78, η2 = 0.225), body fat
percentage (p = 0.375, η2 = 0.082), skeletal muscle mass
(p = 0.102, η2 = 0.188), waist circumference (p = 0.306,
η2 = 0.102) or MAC (p = 0.399, η2 = 0.088).
Physical functioning
Pre-operatively, male participants walked a mean dis-
tance of 513.7 (73.6)m and female participants walked a
Fig. 1 Participant Recruitment and Retention. Flow of participants through the study
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Table 1 Demographic Details
Characteristic All Participants (n = 52) Participants included in the Final Analysis (n = 36) p-value
Age (SD) (years) 62.48 ± 9.03 62.39 (8.82) 0.91
n %
Gender
Male 39 75 26 72 0.73
Female 13 25 10 28
Smoking Status
Never 21 40 12 33 N/A
Stopped > 8 weeks preoperative 28 54 22 61
Stopped < 8 weeks preoperative 1 2 1 3
Current smoker 2 4 1 3
Histological Subtype
Adenocarcinoma 38 73 25 69 0.51
Squamous Cell Carcinoma 14 27 11 31
Neo-adjuvant therapy protocol
CROSS 28 54 15 42 N/A
MAGIC 12 23 12 33
No neoadjuvant therapy 12 23 9 25
ASA Score
1 4 8 4 11 N/A
2 35 67 24 67
3 13 25 8 22
Surgical Approach
Transthoracic 40 77 26 72 0.30
Transhiatial 12 23 10 28
Postoperative Recovery
Hospital Length of Stay (median (IQR) 13.5 (9) 13.0 (7) 0.86
Critical Care Length of Stay (median (IQR) 3.0 (1.75) 3.0 (1.0) 0.07
Postoperative Complications 31 60 19 53 0.72
In-hospital Postoperative Mortality 1 2 0 0 0.29
Data is displayed as mean (standard deviation (SD)) for normally distributed data and as median (interquartile range (IQR) for non-normally distributed data.
Categorical data is presented as frequency (percentage). P-value comparing all participants recruited to those included in the final analysis. N/A = chi squared
test invalid
Table 2 Change in Measures of Anthropometry Post Oesophagectomy
Pre-Surgery (T0) 1-month Post-Surgery (T1) 6-Months Post-Surgery (T2) P-value Multivariate Partial Eta Squared
Anthropometry
Weight (kg) 81.9 (16.4) 76.9(14.8)* 73.8 (13.2)** § < 0.001 0.67
Body Mass Index (kg/m2) 27.8 (4.3) 26.3 (3.9)* 25.3 (3.7)** § < 0.001 0.66
Fat Mass (kg) 27.2 (8.7) 25.5 (8.3)* 22.0 (8.6)** § < 0.001 0.59
Body Fat Percentage (%) 33.6 (7.8) 33.6 (8.2) 30.2 (9.1) § < 0.001 0.55
Fat Free Mass (kg) 54.5 (9.9) 51.3 (8.8)* 50.7 (11.1) § < 0.001 0.48
Skeletal Muscle Mass (kg) 27.0 (5.4) 24.6 (4.9)* 24.6 (4.8) § < 0.001 0.63
Waist Circumference (cm) 97.17 (14.1) 94.5 (11.9) 91.6 (11.2) § 0.002 0.42
Mid-Arm Circumference (cm) 29.8 (3.4) 28.4 (2.9)* 28.9 (2.7) 0.02 0.31
Data is presented as mean (standard deviation) for all variables. P-value for one-way repeated measures ANOVA. *difference between T0 and T1 p < 0.05; **
difference between T1 and T2 p < 0.05; §difference between T0 and T2 p < 0.05
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mean distance of 477.6 (76.0)m during the 6MWT. Sig-
nificant changes in 6MWT distance were observed over
the study period (p < 0.001, η2 = 0.51) (Table 3). Mean
6MWT distance decreased significantly from pre-
surgery (502.6 (76.7)m) to 1-month post-surgery (463.5
(98.4)m) (mean change − 39.1 (95%CI − 68.3 to − 9.9)m,
p = 0.006), and then increased from 1-month post-
surgery to 6-months post-surgery (507.8 (87.8)m) (mean
change 44.3 (95%CI 23.0 to 65.5)m, p < 0.001) (Fig. 2a).
There was no difference between the distance walked
pre-surgery and at 6 months post-surgery (p = 1.00).
There was no impact of treatment approach on 6MWT
distance (p = 0.639, η2 = 0.033). Distance walked during
the 6MWT did not correlate with any measure of body
composition at any timepoint.
Preoperatively, mean HGS was 38.4 (8.0) kg in
males and 23.6 (4.8) kg in females. Mean HGS did
not change over time from pre-surgery (35.5 (9.9) kg);
neither to 1-month post-surgery (33.9 (9.9) kg) nor to
6-months post-surgery (35.8 (10.9) kg) (p = 0.91, η2 =
0.15) (Table 3). There was no impact of treatment ap-
proach on HGS (p = 0.706, η2 = 0.025). HGS corre-
lated positively and strongly with skeletal muscle
mass at T0 (r = 0.78, p < 0.001), T1 (r = 0.73, p <
0.001) and T3 (r = 0.68, p < 0.001).
Habitual physical activity
In the week before surgery, participants spent 7.2 (1.6)
hours/day sedentary, 4.1 (1.5) hours/day engaged in light
intensity activity and a median of 11.5 (31.6) minutes/
day engaging in moderate-to-vigorous intensity activity.
There were significant effects for time for sedentary be-
haviour (p < 0.002, η2 = 0.46), light intensity activity (p <
0.001, η2 = 0.69), and daily MVPA (p < 0.001) (Table 3).
There was no impact of treatment approach on either
sedentary behaviour (p = 0.766, η2 = 0.028) or light in-
tensity activity participation (p = 0.694, η2 = 0.038).
On post-hoc analysis, sedentary behaviour increased
from pre-surgery (7.2 (1.6) hours/day) to 1-month post-
surgery (8.7 (1.7) hours per day) (mean change (1.5
(0.39–2.7 h per day), p < 0.05) and remained elevated at
six-months post-surgery (8.46 (1.7) hours/day) (Fig. 2b).
At 6-months post-surgery, sedentary behaviour was sig-
nificantly higher than pre-operative levels (mean differ-
ence 1.3 (0.4–2.2 h/day), p = 0.05). Sedentary behaviour
did not correlate with skeletal muscle mass at any
timepoint.
In contrast, light intensity activity decreased from pre-
surgery (4.1 (1.5) hours/day) to 1-month post-surgery
(2.3 (0.9) hours per day (mean change − 1.8 (95%CI 2.5
to − 1.1) (p < 0.05) and increased from 1-month post-
surgery to six months post-surgery (3.5 (1.4) hours/day
(mean change 1.2 (95%CI 0.5 to 1.9) hours/day, p < 0.05)
(Fig. 2c). Minutes spent engaging in light intensity activ-
ity did not correlate with skeletal muscle mass at any
timepoint.
Similarly, daily minutes spent engaging in MVPA, de-
creased from a median of 11.5 (31.6) minutes/day pre-
surgery to 4.7 (12.9) minutes/day at 1-month post-
surgery (p < 0.001), and increased from 1-month postop-
erative to 6-months postoperatively (12.5 (24.6) minutes/
day (p = 0.001) (Fig. 2c). At 6-months post-surgery, daily
minutes spent engaging in MVPA was significantly lower
than preoperative levels (p = 0.01).
Health-related quality of life
Health-related quality of life scores are detailed in
Table 4. There were significant changes over time in
multiple domains of quality of life on the QLQ-C30 in-
cluding global health status (p = 0.04), physical function-
ing (p < 0.001), role functioning (p < 0.001), fatigue (p <
0.001), pain (p < 0.001), dyspnoea (p < 0.001), appetite
loss (p = 0.002) and diarrhoea (p = 0.004). Clinically im-
portant (> 10-point) change in physical function and role
function was reported from pre-surgery to 1-month
Table 3 Functional Performance and Physical Activity Post Oesophagectomy
Pre-Surgery (T0) 1-month
Post-Surgery (T1)
6-Months
Post-Surgery (T2)
P-value Multivariate Partial
Eta Squared
Functional Performance
Six Minute Walk Test Distance (m) 502.6 (76.7) 463.5 (98.4)* 507.8 (87.8)** < 0.001 0.51
Hand Grip Strength (kg) 35.5 (9.9) 33.9 (9.9) 35.8 (10.9) 0.15 0.15
Physical Activity
Sedentary behaviour (hours/day) 7.2 (1.6) 8.7 (1.7))* 8.5 (1.7)§ 0.002 0.46
Light intensity activity (hours/day 4.1 (1.5) 2.3 (0.9)* 3.5 (1.4)** < 0.001 0.69
Moderate to vigorous intensity activity (minutes/day) 11.5 (31.6) 4.7 (12.9)* 12.5 (24.6)** § < 0.001 N/A
Adherence to physical activity guidelines n = 11 n = 2 n = 6 N/A N/A
Data is presented as mean (standard deviation) for all continuous variables with the exception of moderate to vigorous intensity activity which is presented as
median (interquartile range). P-value for one-way repeated measures ANOVA and Friedman’s Test. *mean difference between T0 and T1 p < 0.05; ** difference
between T1 and T2 p < 0.05; §difference between T0 and T2 p < 0.05
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post-surgery. Role functioning remained impaired (33-
points lower) at 6-months post-surgery in comparison
with pre-operative values.
Discussion
This study provides a novel prospective evaluation of mea-
sured and perceived change in physical functioning follow-
ing oesophagectomy. It demonstrates that habitual physical
activity participation and perceived role functioning remain
significantly impaired at 6-months post-surgery, despite ex-
ercise capacity recovering to preoperative levels. Consistent
with previous reports, symptom scores worsened postopera-
tively [41] and percentage weight loss was clinically signifi-
cant at 6-months [13]. This significant and clinically relevant
pattern of deterioration highlights the challenges of
transitioning from active treatment to survivorship post-
oesophagectomy and adjusting to the ‘new normal’ after
cancer.
The significant short-term and long-term impairments
in global HR-QOL, and specifically in physical function-
ing and symptom burden, that arise following oesopha-
gectomy are well-reported [3, 29, 41–43]. Consistent
with the pattern of deterioration in HR-QOL reported
by others [41, 42], we observed the largest postoperative
impact in the physical functioning domain, specifically
in the physical function and role function scales, of the
EORTC QOQ-C30. While both scales had improved by
6-months post-surgery, role function remained a clinic-
ally relevant 33-points lower in comparison with pre-
operative values. Clinically important deteriorations in
Fig. 2 Functional Exercise Tolerance and Physical Activity Levels Pre-Surgery and at 1-Month and 6-Months Post-Surgery. Box-plots depicting
distance walked during the six-minute walk test distance (Fig. 1a), percentage walking hours spent sedentary (Fig. 1b) and in light intensity
activity (Fig. 1c) and minutes per day spent in moderate-to-vigorous intensity activity (Fig. 1d) at each timepoint. All participants experienced
significant acute decreases in walk distance and activity levels from pre-surgery to 1-month post-surgery which improved again to 6-months
post-surgery, however all domains of physical activity, including sedentary behaviour, remained impaired at 6-months post-surgery in comparison
to pre-surgery values
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physical functioning are reported with all curative inter-
ventions for oesophageal cancer, including neoadjuvant
therapy, minimally invasive surgery and open surgical re-
section [29]. Importantly however, despite improvements
in the majority of HR-QOL domains over time, patient-
perceived physical functioning remains impaired at 1-
year [41], 2-years [44] and up to 3-years post oesopha-
gectomy [43]. Uniquely, we demonstrate that this pro-
found patient-perceived deterioration in physical health
is matched by clinically relevant changes in habitual ac-
tivity participation.
Functional decline associated with cancer treatment is
typically examined using validated, objective measures of
physical functioning [16]. Using this approach, we ob-
served an acute deterioration in physical activity partici-
pation, as measured by accelerometry, at 1-month post-
oesophagectomy, with physical activity levels and seden-
tary behaviour remaining impaired at 6-months. Consist-
ent with this, we have previously reported that
moderate-to-vigorous intensity activity participation is
significantly lower at 2-years post-oesophagectomy in
comparison with age- and gender-matched controls [30].
Importantly, accelerometry captures habitual activity
participation during waking hours and therefore, engage-
ment in activities of daily living, a construct that is well-
aligned with the role functioning domain of the EORTC
QLQ-C30 [45], which was were perceived by partici-
pants to remain considerably impaired in survivorship.
Role functioning considers an individual’s ability to
engage in activities that are typical for their age and so-
cial setting [45]. In patients with cancer, physical activity
levels are known to reduce at cancer diagnosis and rarely
return to baseline levels following treatment completion
[24]. Compared to those who are inactive or sub-
optimally active, cancer survivors who exercise to rec-
ommended levels consistently report higher HR-QOL
scores, particularly in physical and role functioning do-
mains [25], hypothesised to be driven by the positive ef-
fects of physical fitness on mental wellbeing and social
engagement [46], making physical activity an important
and influential target in survivorship care.
Cardiopulmonary fitness, the primary measure of phys-
ical functioning [16], is impaired by the iterative attritional
impact of multimodal treatment regimens in oesophageal
cancer [27]. We observed a large, clinically important re-
duction (− 39.10 (95%CI − 68.28 to − 9.92) m) in 6MWT
distance at 1-month post-oesophagectomy, consistent
with the decline previously reported in a Japanese cohort
from pre-surgery (563.3 (73.2) m) to pre-hospital dis-
charge (485.3 (85.6) m) [17]. In colorectal resection,
6MWT distance at 4-weeks post-surgery is discriminative
of older age, poorer physical status, open resection and
occurrence of postoperative complications, and therefore
is a valuable indicator of early physical recovery [47].
While the 6MWT provides a valid measure of functional
exercise status in patients with cancer [48], reliability and
reproducibility data is lacking [16], and walking distances
correlate poorly with cardiopulmonary fitness in
Table 4 Health Related Quality of Life Post Oesophagectomy
Pre-Surgery (T0) 1-month Post-Surgery (T1) 6-Months Post-Surgery (T2) P-value
Global Health Status 66.7 (16.7) 58.3 (16.7)* 66.7 (16.7) 0.04
Functional Scales
Physical Function 93.3 (20.0) 73.3 (40.0)* 86.7 (40.0)** < 0.001
Role Function 100.0 (33.3) 50.0 (33.3)* 66.7 (33.3)** < 0.001
Emotional Function 91.7 (33.3) 91.7 (25.0) 91.7 (16.7) 0.337
Cognitive Function 83.3 (33.3) 83.3 (33.3) 100 (16.7) 0.545
Social Function 66.7 (33.3) 66.7 (50.0) 66.7 (50.0) 0.401
Symptom Scales
Fatigue 22.2 (22.2) 33.3 (22.2)* 33.3 (22.2)** < 0.001
Nausea/Vomiting 0.0 (16.7) 16.7 (33.3)* 0.0 (16.7) 0.03
Pain 0.0 (16.7) 33.3 (16.7)* 0.0 (33.3) < 0.001
Dyspnoea 0.0 (0.0) 33.3 (0.0)* 33.3 (33.3) < 0.001
Insomnia 33.3 (66.7) 33.3 (41.7) 33.3 (33.3) 0.284
Appetite Loss 0.0 (33.3) 33.3 (33.3)* 0.0 (33.3) 0.002
Constipation 0.0 (0.0) 0.0 (33.3) 0.0 (0.0) 0.497
Diarrhoea 0.0 (0.0) 33.3 (33.3)* 0.0 (33.3) 0.004
Financial Difficulties 33.3 (66.7) 33.3 (66.7) 33.3 (66.7) 0.232
Data is presented as median (inter-quartile range) for all variables. P-value for Friedman’s Test
*difference between T0 and T1 p < 0.05; ** difference between T1 and T2 p < 0.05
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comparison with incremental walking protocols [49]. In
contrast to our observation that 6MWT distance returned
to preoperative values at 6-months postoperatively, sug-
gesting an element of natural recovery in this cohort, a
study in a Japanese cohort, utilising the highly sensitive
cardiopulmonary exercise test, reported a reduction in ex-
ercise capacity from 1186.6 (300.30) ml/min pre-
oesophagectomy to 916.1 (238.6) ml/min 3-months post-
operatively (p < 0.0001) following open resection [50]. Fur-
thermore, we previously reported significantly lower
walking distance in disease-free patients up to 2-years
post-oesophagectomy (558.33 (146.43)m) in comparison
with age- and gender-matched controls (773.48 (114.00)
m) using a progressive, incremental walking protocol [30].
Therefore, it is likely that cardiopulmonary fitness remains
impaired in oesophageal cancer survivorship; however fur-
ther prospective evaluations using sensitive measures of
fitness are required.
The nutritional challenge of recovery post-
oesophagectomy is well-documented. Consistent with pre-
vious reports, in this cohort weight loss remained signifi-
cant at 6-months [13] and symptom burden was
considerable in early post-operative recovery. While HGS,
a reliable indicator of whole-body muscle strength and nu-
tritional status [51], remained stable over the study period,
we have previously reported significant deficits in grip
strength with loss of lean body mass during neo-adjuvant
therapy [14]. Furthermore, sarcopenia remains prevalent
in survivorship with 35% of patients sarcopenic at 1-year
post-oesophagectomy [13]. This complex interplay be-
tween nutritional insufficiency and physical deterioration
makes survivorship rehabilitation particularly challenging.
We recently designed, implemented and evaluated the Re-
habilitation Strategies Following Oesophagogastric Cancer
(ReStOre) programme, a rehabilitation programme for
oesophagogastric survivorship comprising exercise train-
ing, individualised dietary counselling and multidisciplin-
ary education, with a strong focus on self-management
[52–54], leading to clinically important improvements in
cardiopulmonary fitness [52], inflammatory status [53],
and multiple domains of HR-QOL [54]. The ReStOre
programme, the first exemplar in oesophagogastric cancer
rehabilitation, included participants up to 5-years post-
surgery, however rehabilitative measures implemented
earlier in survivorship, particularly within the first 6-
months, are likely to have greatest effect [32] and address
the issues identified by this work. Consistent with
established clinical rehabilitation models, cancer re-
habilitation commencing from diagnosis and continu-
ing through the treatment trajectory, may have a key
role in attenuating the impact of multiple attritional
oncologic treatments, optimising patient condition for
surgical intervention and supporting patients through
recovery and into survivorship [8, 31].
This work has some limitations which are acknowl-
edged. Firstly, participant retention was challenging with
69% of those initially recruited (n = 52) available for
evaluation at 6-months (n = 36). This is an inevitable
challenge of prospective data collection in a cohort
undergoing complex surgical and medical interventions.
Reasons for attrition are reported and were largely at-
tributed to disease progression and protracted postoper-
ative morbidity. Importantly, those included in the final
analyses had comparable baseline characteristics to those
lost to follow-up. Nonetheless, the final study cohort
represent those who are recovering relatively well at 6
months post-surgery and therefore generalisability is
limited. The sample size is comparable to other pub-
lished work in this field [17, 30, 50]. The use of objective
measures of physical functioning is a considerable
strength of this work. By employing these methods, mul-
tiple measurable and modifiable targets for physical re-
habilitation were identified which were well-aligned with
patient-reported survivorship issues.
Conclusions
These results add to the growing evidence that improve-
ments in oncological outcomes in oesophageal cancer
have led to a newly emergent cohort of cancer survivors
with considerable physical and nutritional concerns. Im-
portantly, results identify deficits in both perceived role
functioning and measured activity participation in recov-
ery, suggesting that patients experience considerable
challenges adjusting to the ‘new normal’ in survivorship.
Multidisciplinary rehabilitation with a strong focus on
self-management and overcoming barriers to habitual
activity participation is warranted.
Abbreviations
6MWT: 6-min walk test; BMI: Body mass index; EORTC: European Organisation
for Research and Treatment of Cancer; FFM: Fat free mass; HDU: High
dependency unit; HR-QOL: Health-related quality of life; IQR: Interquartile
range; LOS: Length of stay; MAC: Mid-arm circumference; MWPA: Moderate-
to-vigorous intensity physical activity; POD: Postoperative day; SD: Standard
deviation
Acknowledgements
We would like to acknowledge the assistance and support of the Wellcome
Trust/HRB Clinical Research Facility at St James’ Hospital in providing a
dedicated environment for the conduct of high quality clinical research
activities. We thank Sinead King, Upper Gastrointestinal Database Manager, St
James’s Hospital for her assistance with data collection. We also wish to
thank the study participants for kindly agreeing to take time to participate.
Authors’ contributions
Study design and concept was developed by EMG, SLD, JOS, JVR and JH.
EMG, AEB, SLD, LON, JG and GF completed data collection and
management. Participant recruitment and medical oversight was provided
by JAE and JVR. EMG and AEB conducted statistical analysis. EMG prepared
the manuscript for publication. All authors read and approved the final
manuscript.
Funding
This project was funded through a grant awarded by the Health Research
Board, Ireland (POR HRA-POR-2014-535). The Health Research Board had no
Guinan et al. BMC Cancer          (2019) 19:682 Page 9 of 11
role in the design of the study, in the collection, analysis, and interpretation
of data or in writing the manuscript.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Ethics approval and consent to participate
Ethical approval was obtained from the SJH–Tallaght Hospital Joint Research
Ethics Committee (Reference number 2014–11 Chairman’s Action (2)).
Participants provided written informed consent.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1School of Medicine, Trinity College Dublin, Dublin, Ireland. 2Department of
Clinical Medicine, School of Medicine, Trinity College Dublin, Dublin, Ireland.
3School of Biological Sciences, Dublin Institute of Technology, Dublin, Ireland.
4Discipline of Physiotherapy, School of Medicine, Trinity College Dublin,
Dublin, Ireland. 5Department of Surgery, St. James’ Hospital, Dublin, Ireland.
6Trinity Translational Medicine Institute, Department of Surgery, Trinity
College Dublin, Dublin, Ireland.
Received: 3 November 2018 Accepted: 26 June 2019
References
1. Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, D'Journo XB,
Griffin SM, Holscher AH, Hofstetter WL, Jobe BA, et al. International
consensus on standardization of data collection for complications
associated with Esophagectomy: Esophagectomy complications consensus
group (ECCG). Ann Surg. 2015;262(2):286–94.
2. Reynolds JV, Preston SR, O'Neill B, Baeksgaard L, Griffin SM, Mariette C, Cuffe
S, Cunningham M, Crosby T, Parker I, et al. ICORG 10-14: NEOadjuvant trial
in adenocarcinoma of the oEsophagus and oesophagoGastric junction
international study (neo-AEGIS). BMC Cancer. 2017;17(1):401.
3. Donohoe CL, McGillycuddy E, Reynolds JV. Long-term health-related quality
of life for disease-free esophageal cancer patients. World J Surg. 2011;35(8):
1853–60.
4. Wong MCS, Hamilton W, Whiteman DC, Jiang JY, Qiao Y, Fung FDH, Wang
HHX, Chiu PWY, Ng EKW, Wu JCY, et al. Global incidence and mortality of
oesophageal cancer and their correlation with socioeconomic indicators
temporal patterns and trends in 41 countries. Sci Rep. 2018;8(1):4522.
5. Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R.
Guidelines for the management of oesophageal and gastric cancer. Gut.
2011;60(11):1449–72.
6. Feeney C, Hussey J, Carey M, Reynolds JV. Assessment of physical fitness for
esophageal surgery, and targeting interventions to optimize outcomes.
Diseases of the esophagus : official journal of the International Society for
Diseases of the Esophagus / ISDE. 2010;23(7):529–39.
7. Shapiro J, van Lanschot JJ, Hulshof MC, van Hagen P, van Berge
Henegouwen MI, Wijnhoven BP, van Laarhoven HW, Nieuwenhuijzen GA,
Hospers GA, Bonenkamp JJ, et al. Neoadjuvant chemoradiotherapy plus
surgery versus surgery alone for oesophageal or junctional cancer (CROSS):
long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):
1090–8.
8. Guinan EM, Dowds J, Donohoe C, Reynolds JV, Hussey J. The
physiotherapist and the esophageal cancer patient: from prehabilitation to
rehabilitation. Diseases of the esophagus : official journal of the
International Society for Diseases of the Esophagus / ISDE. 2017;30(1):1–12.
9. Ryan AM, Healy LA, Power DG, Rowley SP, Reynolds JV. Short-term
nutritional implications of total gastrectomy for malignancy, and the impact
of parenteral nutritional support. Clin Nutr. 2007;26(6):718–27.
10. Donohoe CL, Ryan AM, Reynolds JV: Cancer cachexia: mechanisms and
clinical implications. Gastroenterol Res Pract 2011, 2011:601434.
11. Elliott JA, Docherty NG, Eckhardt HG, Doyle SL, Guinan EM, Ravi N, Reynolds
JV, le Roux CW. Weight loss, satiety, and the postprandial gut hormone
response after Esophagectomy: a prospective study. Ann Surg. 2016;266(1):
82–90.
12. Heneghan HM, Zaborowski A, Fanning M, McHugh A, Doyle S, Moore J, Ravi
N, Reynolds JV. Prospective study of malabsorption and malnutrition after
esophageal and gastric Cancer surgery. Ann Surg. 2015;262(5):803–7.
13. Elliott JA, Doyle SL, Murphy CF, King S, Guinan EM, Beddy P, Ravi N,
Reynolds JV. Sarcopenia: prevalence, and impact on operative and
oncologic outcomes in the multimodal Management of Locally Advanced
Esophageal Cancer. Ann Surg. 2017;266(5):822–30.
14. Guinan EM, Doyle SL, Bennett AE, O'Neill L, Gannon J, Elliott JA, O'Sullivan J,
Reynolds JV, Hussey J. Sarcopenia during neoadjuvant therapy for
oesophageal cancer: characterising the impact on muscle strength and
physical performance. Supportive care in cancer : official journal of the
Multinational Association of Supportive Care in Cancer. 2018;26(5):1569–76.
15. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos
VE. Prevalence and clinical implications of sarcopenic obesity in patients
with solid tumours of the respiratory and gastrointestinal tracts: a
population-based study. Lancet Oncol. 2008;9(7):629–35.
16. Granger CL, McDonald CF, Parry SM, Oliveira CC, Denehy L. Functional
capacity, physical activity and muscle strength assessment of individuals
with non-small cell lung cancer: a systematic review of instruments and
their measurement properties. BMC Cancer. 2013;13:135.
17. Tatematsu N, Hasegawa S, Tanaka E, Sakai Y, Tsuboyama T. Impact of
oesophagectomy on physical fitness and health-related quality of life in
patients with oesophageal cancer. Eur J Cancer Care (Engl).
2013;22(3):308–13.
18. Whibley J, Peters CJ, Halliday LJ, Chaudry AM, Allum WH. Poor performance
in incremental shuttle walk and cardiopulmonary exercise testing predicts
poor overall survival for patients undergoing esophago-gastric resection.
European journal of surgical oncology : the journal of the European Society
of Surgical Oncology and the British Association of Surgical Oncology. 2018;
44(5):594–9.
19. Lund M, Alexandersson von Döbeln G, Nilsson M, Winter R, Lundell L, Tsai
JA, Kalman S. Effects on heart function of neoadjuvant chemotherapy and
chemoradiotherapy in patients with cancer in the esophagus or
gastroesophageal junction – a prospective cohort pilot study within a
randomized clinical trial. Radiat Oncol. 2015;10(1):16.
20. von Dobeln GA, Nilsson M, Adell G, Johnsen G, Hatlevoll I, Tsai J, Lundell L,
Lund M, Lind P. Pulmonary function and cardiac stress test after
multimodality treatment of esophageal cancer. Pract Radiat Oncol. 2016;
6(3):e53–9.
21. Jack S, West MA, Raw D, Marwood S, Ambler G, Cope TM, Shrotri M,
Sturgess RP, Calverley PM, Ottensmeier CH, et al. The effect of neoadjuvant
chemotherapy on physical fitness and survival in patients undergoing
oesophagogastric cancer surgery. European journal of surgical oncology :
the journal of the European Society of Surgical Oncology and the British
Association of Surgical Oncology. 2014;40(10):1313–20.
22. Feeney C, Reynolds JV, Hussey J. Preoperative physical activity levels and
postoperative pulmonary complications post-esophagectomy. Diseases of
the esophagus : official journal of the International Society for Diseases of
the Esophagus / ISDE. 2011;24(7):489–94.
23. Guinan EM, Connolly EM, Kennedy MJ, Hussey J. The presentation of
metabolic dysfunction and the relationship with energy output in breast
cancer survivors: a cross-sectional study. Nutr J. 2013;12:99.
24. Broderick JM, Hussey J, Kennedy MJ, O'Donnell DM. Testing the 'teachable
moment' premise: does physical activity increase in the early survivorship
phase? Supportive care in cancer : official journal of the Multinational
Association of Supportive Care in Cancer. 2014;22(4):989–97.
25. Husson O, Mols F, Ezendam NP, Schep G. Van de poll-Franse LV: health-
related quality of life is associated with physical activity levels among
colorectal cancer survivors: a longitudinal, 3-year study of the PROFILES
registry. J Cancer Surviv. 2015;9(3):472–80.
26. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A,
Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer
survivors: a systematic review. J Natl Cancer Inst. 2012;104(11):815–40.
27. ON L, Moran J, Guinan EM, Reynolds JV, Hussey J. Physical decline and its
implications in the management of oesophageal and gastric cancer: a
systematic review. J Cancer Surviv. 2018;12(1):601–18.
28. Daster S, Soysal SD, Stoll L, Peterli R, von Flue M, Ackermann C. Long-term
quality of life after Ivor Lewis esophagectomy for esophageal cancer. World
J Surg. 2014;38(9):2345–51.
Guinan et al. BMC Cancer          (2019) 19:682 Page 10 of 11
29. Scarpa M, Valente S, Alfieri R, Cagol M, Diamantis G, Ancona E, Castoro C.
Systematic review of health-related quality of life after esophagectomy for
esophageal cancer. World journal of gastroenterology : WJG. 2011;17(42):
4660–74.
30. Gannon JA, Guinan EM, Doyle SL, Beddy P, Reynolds JV, Hussey J. Reduced
fitness and physical functioning are long-term sequelae after curative
treatment for esophageal cancer: a matched control study. Diseases of the
esophagus : official journal of the International Society for Diseases of the
Esophagus / ISDE. 2017;30(8):1–7.
31. O'Neill L, Gannon J, Guinan EM, Reynolds JV, Hussey J. Multidisciplinary
rehabiltiation across the esophageal cancer journey. J Thoracic Dis. 2017;
9(12):e1140–2.
32. Courneya KS, Friedenreich CM. Framework PEACE: an organizational model
for examining physical exercise across the cancer experience. Ann Behav
Med. 2001;23(4):263–72.
33. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ,
Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, et al. Perioperative
chemotherapy versus surgery alone for resectable gastroesophageal cancer.
N Engl J Med. 2006;355(1):11–20.
34. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge
Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA,
Bonenkamp JJ, et al. Preoperative chemoradiotherapy for esophageal or
junctional cancer. N Engl J Med. 2012;366(22):2074–84.
35. Donohoe CL, O'Farrell NJ, Ravi N, Reynolds JV. Evidence-based selective
application of transhiatal esophagectomy in a high-volume esophageal
center. World J Surg. 2012;36(1):98–103.
36. Donohoe CL, Healy LA, Fanning M, Doyle SL, Hugh AM, Moore J, Ravi N,
Reynolds JV. Impact of supplemental home enteral feeding
postesophagectomy on nutrition, body composition, quality of life, and
patient satisfaction. Diseases of the esophagus : official journal of the
International Society for Diseases of the Esophagus / ISDE. 2017;30(9):1–9.
37. ATS statement: guidelines for the six-minute walk test. American journal of
respiratory and critical care medicine 2002, 166(1):111–117.
38. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA,
Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, et al. American College of
Sports Medicine roundtable on exercise guidelines for cancer survivors. Med
Sci Sports Exerc. 2010;42(7):1409–26.
39. Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical
activity in the United States measured by accelerometer. Med Sci Sports
Exerc. 2008;40(1):181–8.
40. Fayers PAN, Bjordal K, Groenvold M, Curran D, Bottomley A. The EORTC
QLQ-C30 scoring manual. In., 3rd edition edn. Brussels: European
organisation for research and treatment of. Cancer. 2001.
41. Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ. Prospective
evaluation of quality of life in patients with localized oesophageal cancer
treated by multimodality therapy or surgery alone. Br J Surg. 2006;93(9):
1084–90.
42. van Meerten E, van der Gaast A, Looman CW, Tilanus HW, Muller K, Essink-
Bot ML. Quality of life during neoadjuvant treatment and after surgery for
resectable esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2008;71(1):
160–6.
43. Lagergren P, Avery KN, Hughes R, Barham CP, Alderson D, Falk SJ, Blazeby
JM. Health-related quality of life among patients cured by surgery for
esophageal cancer. Cancer. 2007;110(3):686–93.
44. Schneider L, Hartwig W, Aulmann S, Lenzen C, Strobel O, Fritz S, Hackert T,
Keller M, Buchler MW, Werner J. Quality of life after emergency vs. elective
esophagectomy with cervical reconstruction. Scandinavian journal of surgery
: SJS : official organ for the Finnish Surgical Society and the. Scandinavian
Surgical Society. 2010;99(1):3–8.
45. Gamper EM, Petersen MA, Aaronson N, Costantini A, Giesinger JM, Holzner
B, Kemmler G, Oberguggenberger A, Singer S, Young T, et al. Development
of an item bank for the EORTC role functioning computer adaptive test
(EORTC RF-CAT). Health Qual Life Outcomes. 2016;14:72.
46. Dimeo FC. Effects of exercise on cancer-related fatigue. Cancer. 2001;92(6
Suppl):1689–93.
47. Pecorelli N, Fiore JF Jr, Gillis C, Awasthi R, Mappin-Kasirer B, Niculiseanu P,
Fried GM, Carli F, Feldman LS. The six-minute walk test as a measure of
postoperative recovery after colorectal resection: further examination of its
measurement properties. Surg Endosc. 2016;30(6):2199–206.
48. Schmidt K, Vogt L, Thiel C, Jager E, Banzer W. Validity of the six-minute walk
test in cancer patients. Int J Sports Med. 2013;34(7):631–6.
49. Moran J, Wilson F, Guinan E, McCormick P, Hussey J, Moriarty J. The
preoperative use of field tests of exercise tolerance to predict postoperative
outcome in intra-abdominal surgery: a systematic review. J Clin Anesth.
2016;35:446–55.
50. Taguchi S, Osugi H, Higashino M, Tokuhara T, Takada N, Takemura M, Lee S,
Kinoshita H. Comparison of three-field esophagectomy for esophageal
cancer incorporating open or thoracoscopic thoracotomy. Surg Endosc.
2003;17(9):1445–50.
51. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin
FC, Michel JP, Rolland Y, Schneider SM, et al. Sarcopenia: European
consensus on definition and diagnosis: report of the European working
group on sarcopenia in older people. Age Ageing. 2010;39(4):412–23.
52. O'Neill L, Guinan E, Doyle SL, Elliott JA, O'Sullivan J, Reynolds JV, Hussey J.
Rehabilitation strategies following esophageal cancer (the ReStOre trial): a
feasibility study. Dis Esophagus. 2017;30(5):1–8.
53. Guinan EM, Doyle SL, O'Neill L, Dunne MR, Foley EK, O'Sullivan J, Reynolds
JV, Hussey J. Effects of a multimodal rehabilitation programme on
inflammation and oxidative stress in oesophageal cancer survivors: the
ReStOre feasibility study. Supportive care in cancer : official journal of the
Multinational Association of Supportive Care in Cancer. 2016;25(3):749–56.
54. Bennett AM, ON L, Connolly D, Guinan EM, Boland L, Doyle SL, O'Sullivan J,
Reynolds JV, Hussey J. Patient experiences of a physiotherapy-led
multidisciplinary rehabilitative intervention after successful treatment for
oesophago-gastric cancer. Supportive care in cancer : official journal of the
Multinational Association of Supportive Care in Cancer. 2018;26(8):2615–23.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Guinan et al. BMC Cancer          (2019) 19:682 Page 11 of 11
